Federal award (DELIVERY ORDER, fiscal year 2022)
Recipient: DMS PHARMACEUTICAL GROUP INC
Awarding agency: Department of Defense / Defense Logistics Agency
Funding agency: Department of Defense / Defense Logistics Agency
Period of performance: 2022-11-07 to 2022-11-30
Current total value of award: $12773.88
Description: 4559051508!TYSABRI 300 MG/15 ML VIAL 15ML